- ALLIED HEALTHCARE PRODS INC has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. The company has reported a trend of declining earnings per share over the past two years. During the past fiscal year, ALLIED HEALTHCARE PRODS INC reported poor results of -$0.15 versus -$0.06 in the prior year.
- The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Health Care Equipment & Supplies industry. The net income has significantly decreased by 247.3% when compared to the same quarter one year ago, falling from -$0.28 million to -$0.97 million.
- Current return on equity is lower than its ROE from the same quarter one year prior. This is a clear sign of weakness within the company. Compared to other companies in the Health Care Equipment & Supplies industry and the overall market, ALLIED HEALTHCARE PRODS INC's return on equity significantly trails that of both the industry average and the S&P 500.
- The gross profit margin for ALLIED HEALTHCARE PRODS INC is rather low; currently it is at 22.80%. Regardless of AHPI's low profit margin, it has managed to increase from the same period last year. Despite the mixed results of the gross profit margin, AHPI's net profit margin of -10.63% significantly underperformed when compared to the industry average.
- The share price of ALLIED HEALTHCARE PRODS INC has not done very well: it is down 16.14% and has underperformed the S&P 500, in part reflecting the company's sharply declining earnings per share when compared to the year-earlier quarter. The fact that the stock is now selling for less than others in its industry in relation to its current earnings is not reason enough to justify a buy rating at this time.
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. The Health Care sector as a whole closed the day down 0.9% versus the S&P 500, which was down 0.2%. Laggards within the Health Care sector included Aurinia Pharmaceuticals ( AUPH), down 6.8%, Aoxing Pharmaceutical ( AXN), down 1.5%, China Pharma ( CPHI), down 3.4%, Allied Healthcare Products ( AHPI), down 1.8% and American Shared Hospital Services ( AMS), down 4.5%. TheStreet Ratings Group would like to highlight 3 stocks that pushed the sector lower today: Allied Healthcare Products ( AHPI) is one of the companies that pushed the Health Care sector lower today. Allied Healthcare Products was down $0.04 (1.8%) to $2.04 on light volume. Throughout the day, 1,183 shares of Allied Healthcare Products exchanged hands as compared to its average daily volume of 12,600 shares. The stock ranged in price between $2.04-$2.09 after having opened the day at $2.09 as compared to the previous trading day's close of $2.08. Allied Healthcare Products, Inc. manufactures, markets, and distributes respiratory care products, medical gas equipment, and emergency medical products in Canada, Mexico, Central and South America, Europe, the Middle East, and the Far East. Allied Healthcare Products has a market cap of $16.0 million and is part of the drugs industry. Shares are down 8.8% year-to-date as of the close of trading on Wednesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. TheStreet Ratings rates Allied Healthcare Products as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity, poor profit margins and generally disappointing historical performance in the stock itself. Highlights from TheStreet Ratings analysis on AHPI go as follows: